[ad_1]
The Food and Drug Administration has issued guidelines for manufacturers of electronic cigarettes. The instructions include information on how e-cigarettes should be marketed and how companies should solve public health problems. (Reuters)
Private insurance will be needed to cover free HIV preventive drugs. The US Task Force on Preventive Services has given a Grade A recommendation to PrEP treatments, which means that private insurers must cover the drug. (NBCC)
Juul said sales were picking up after a decline last year. The company told investors that first-quarter sales were $ 528 million, up 23 percent from last year. Juul said the 2018 drop was caused by the removal of flavored vape pods from the market. (Bloomberg)
The FDA is holding a two-day hearing on the benefits and risks of high doses of opioids. The agency is questioning the opportunity to reduce the use of large daily doses of opioids. The FDA hears expert and public comments about the clinical benefits and potential risks of these drugs. (BioPharma Diving)
Keytruda has been approved for a new indication to treat a type of cancer of the head and neck. The treatment has been approved by the FDA for squamous cell carcinoma of the head and neck, which may include tumors in the mouth, tongue, nose, sinuses, throat and lymph nodes of the neck. (Reuters)
[ad_2]
Source link